INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
MA
Mayes Patrick AEVP & Chief Scientific Officer
INCYINCYTE CORP
Option exercise · 10b5-1 plan
M$235K
2,207 sh
Aug 5, 2026Aug 7, 2026
Page 555 of 1701
← PrevNext →
traded Aug 5, 2026
+2d
SEC Form 4

Evidence

61
PD
Peck Michael DPRESIDENT
FTECXFirst Trust Enhanced Private Credit Fund
Open-market purchase
BUY$1.50M
159.2K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

61
CE
Chad EisenbergTreasurer
VFLEXFIRST TRUST ALTERNATIVE OPPORTUNITIES FUND
Open-market purchase
BUY$1.50M
54.2K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

61
PD
Peck Michael DPresident
VFLEXFIRST TRUST ALTERNATIVE OPPORTUNITIES FUND
Open-market purchase
BUY$5.00M
180.8K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

58
CE
Chad EisenbergTREASURER
FTECXFirst Trust Enhanced Private Credit Fund
Open-market purchase
BUY$400K
42.5K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

42
PM
Powell MaryDirector, Chief Executive Officer
RUNSunrun Inc.
Open-market sale
SELL$316K
24.0K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

39
LP
Loop PaulaDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
8,336 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

39
AD
Abajian DannyChief Financial Officer
RUNSunrun Inc.
Open-market sale
SELL$218K
16.5K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

39
SJ
Steele JeannaChief Legal & People Officer
RUNSunrun Inc.
Open-market sale
SELL$131K
9,897 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

38
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$3,497
819 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

38
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$25K
5,905 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

38
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$6,431
1,506 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

38
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,938
1,859 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

37
KJ
Kuang JinCFO
VPLMVoip-pal.com Inc
Open-market sale
SELL$368
36.5K sh
Jun 29, 2026Jul 7, 2026
traded Jun 29, 2026
+8dSEC Form 4

Evidence

36
GG
Giterman Arthur G.Director, CEO and CFO
MYNDMynd.ai, Inc.
Grant or award
A$2.70M
7.09M sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

36
KG
Krause Allyson G.General Counsel
MYNDMynd.ai, Inc.
Grant or award
A$1.01M
2.66M sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

36
BM
Barak MariaChief Accounting Officer
RUNSunrun Inc.
Open-market sale
SELL$23K
1,747 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

36
LY
Liu YingDirector
EXFYExpensify, Inc.
Grant or award
A—
123.8K sh
May 22, 2026Jul 7, 2026
traded May 22, 2026
+46dSEC Form 4

Evidence

36
PE
Pao EllenDirector
EXFYExpensify, Inc.
Grant or award
A—
123.8K sh
May 22, 2026Jul 7, 2026
traded May 22, 2026
+46dSEC Form 4

Evidence

35
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$2.08M
10.8K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

33
SI
Solomon Lance I.Chief Product Officer
MYNDMynd.ai, Inc.
Grant or award
A$442K
1.16M sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

33
SB
Strand Michael B.Chief Revenue Officer
MYNDMynd.ai, Inc.
Grant or award
A$351K
923.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

33
CM
Carlson MeganCAO and SVP, Finance
BFLYButterfly Network, Inc.
Open-market sale
SELL$329K
41.3K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,486
1,737 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$2,293
532 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

32
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$387K
2,009 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$448
104 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$1,099
255 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

31
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$1.37M
7,206 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.30M
146.9K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
LS
Leung Lim Kin SimonDirector
MYNDMynd.ai, Inc.
Grant or award
A$225K
592.1K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$377K
16.1K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
MM
Merle Denise MDirector
MYNDMynd.ai, Inc.
Grant or award
A$150K
394.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
MR
Mendelson RobinDirector
MYNDMynd.ai, Inc.
Grant or award
A$150K
394.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5.20M
239.4K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

30
GA
Getz Joel A.Director
MYNDMynd.ai, Inc.
Grant or award
A$150K
394.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$693
138 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$158
31 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

29
TJ
Treseder Oluwadara JohnsonDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$216K
1,875 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

29
SS
Sankar ShyamSee Remarks
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$19.50M
150.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence